I want to land an agent and be published, you want to land an agent and be published. I scream, you scream, we all scream for representation.
Rejection is simply part of the process of being a writer. It stings, it’s hard to get past. But what’s the other choice? Quit? If that’s an option for you, then it’s probably the best course of action. Most of us, though, can’t imagine a life that doesn’t involve writing. So, it’s not that quitting isn’t an option in the “I’m too tough to quit” way, it’s that it’s not an option, period.
But what should you do? When do you take it to heart, when do you wonder if it’s you or them, when do you make (God help us) more changes to your MS?
- If you’re not getting any requests for fulls or partials, work on your query and synopsis. You’ve got a solid story, but if no one thinks it’s “right” for them, then you’re missing something. Start there. Send it to a crit group. Do research on query letter and synopsis writing.
- If you get a request and you still get a generic no, go directly to beta readers, crit group, or crit partners. Explore everything to see if you can make your story stronger. But stand by your story. If you know that’s how it was meant to be written, believe in yourself. There’s a middle line.
- If you get a rejection with feedback, by all means, consider it strongly. But not too strongly. Take a step back. Read your story. Can you see where the feedback can be coming from? Again, go to the betas and critique sources. Evaluate. Stand by your story. It’s the same idea, but this time, you at least have something specific to look for.
- Most importantly, don’t give up. Ever.
All this to say, don’t resent the challenge. Stop complaining about how difficult it is. Nobody cares.
via So You Can’t Seem to Land an Agent—Now What?.
I like this site very much, Its a rattling nice position to read
and receive information.Raise range
Shannan_C | Shannan_C
The gene, Whrn, encodes the scaffolding protein whirlin, and genetic abnormalities of WHRN are the source of deafness in patients with DFNB31 and USH2D; likewise, Whrn abnormalities are responsible for deafness in whirler mutant mice buy priligy generic In this study, we also report that SALL4 dynamically recruits the histone demethylase LSD1 and the H3K79 methyltransferase DOT1L
cialis with priligy In breast cancer patients, at the tumour level, Tamoxifen PCH acts primarily as an antioestrogen, preventing oestrogen binding to the oestrogen receptor
cytotec rx Tom Platz During the year, is there a particular amount or number of months or weeks that you do not take steroids